Advanced Research Institute
Ensuring Seamless Clinical Trial Management

A leading clinical trials research company in Florida, Advanced Research Institute (ARI) is ideally positioned to help life science firms bring new and advanced products to market. Drawing on its mission to be a strong advocate of patient rights and accessible health care, the company facilitates clients, including pharmaceutical, biotech, and medical device companies, in performing clinical trials by working closely with all stakeholders. It is committed to testing the safety and efficacy of new devices and medicines by ensuring compliance with FDA standards.

With extensive industry experience, determination to stay ahead of medical advancements, a comprehensive service suite, and a team of industry experts, ARI masters the art of ensuring clinical trial success. Access to top medical institutions and monitoring tools also add to its annals of excellence. The firm prides itself on gaining a sterling reputation in the clinical trials space, assisting over 250 research studies in the past 22 years.

“It’s our unwavering commitment to perform successful clinical trials, from Phase I to Phase IV, in a high-quality research environment that sets us apart from the rest,” says Kiran Mantripragada, CEO of ARI. “Our goal is to provide the community with better access to clinical solutions.”

The multi-specialty company caters small to large multinational trials in therapeutic areas, including gastroenterology, oncology, allergy, rheumatology, urology, obstetrics, gynecology, and internal medicine.

The team adopts a collaborative approach while engaging with clients. A typical engagement begins with its team gaining a comprehensive understanding of customer goals and timelines for project completion. Based on these insights, it designs and develops the best strategy to drive their clinical trials to success.

As a primary goal, ARI undertakes patient enrollment and screening and retention services for conducting clinical trials. Typically patients volunteer for participation in trials when their present medications are unresponsive or they lack access to the right medications. Each patient has to meet certain inclusion-exclusion criteria, depending on project requirements and standards. They should be diagnosed with the disease and should not be consuming certain medicines. If it is a female participant, they should not be pregnant or conceiving during the time of treatment.

After the requirements are met for clinical trials, ARI enrolls patients to study efficacy and safety of new medicines that could cure their disease. Their medication journey is consistently recorded and monitored to find the medicine’s effectiveness.

ARI’s capabilities were put to test when it recently helped a patient find a new medication for his condition. The patient, diagnosed with inflammatory bowel disease (IBD), approached ARI as he was constantly suffering from abdominal pain, cramps, diarrhea, and bleeding even after consuming the costly medicines prescribed to him. His life had turned upside down with deteriorating health. As a last ray of hope, he wanted to try emerging medications by participating in clinical trials. ARI analyzed his health conditions and tried a new method of treatment with a new drug, which helped improve the quality of the patient’s life.

Successes like these stand testament to ARI’s excellence in conducting clinical trials. What truly sets the company a notch above the rest is its expert team of 17 doctors and staff with 100+ years of combined experience in clinical research. With the right combination of best practices, industry expertise, and a commitment to answering the hopes of patients for better clinical treatments and devices, ARI is a beacon of excellence in bringing medicines and devices to market.